Dyadic to Join the New Russell Microcap Index
June 14 2005 - 9:01AM
Business Wire
Dyadic International, Inc. (AMEX:DIL), a biotechnology company,
announced today that it is scheduled to join the new Russell
Microcap(TM) Index when the Russell Investment Group reconstitutes
its family of U.S. indexes on June 24. Russell recently posted a
preliminary membership list at
http://www.russell.com/us/indexes/us/reconstitution/microcap_adds.asp.
The Russell Microcap Index will be comprised of the smallest 1,000
securities in the small-cap Russell 2000(R) Index plus the next
1,000 companies, based on a ranking of all U.S. equities by market
capitalization and will not include less-regulated OTC bulletin
board securities or pink-sheet stocks priced under $1. This new
index offers managers and other investors a comprehensive, unbiased
barometer to compare their performance against the genuine microcap
marketplace of stocks. "We're pleased to be named to the Russell
Microcap Index," said Mark Emalfarb, Dyadic's Chief Executive
Officer. "This will increase Dyadic's visibility with investors and
institutions that rely on the Russell Indexes as a key part of
their investment strategy." The Russell indexes are widely used by
investment managers and institutional investors for index funds and
as benchmarks for both passive and active investment strategies.
More than $2.5 trillion in assets currently are benchmarked to
them. Investment managers who oversee these funds purchase shares
of member stocks according to that company's weighting in the
particular index. Companies slated for the Russell Microcap were
ranked as of May 31, 2005, by total market capitalization and
weighted based on free-float adjustment, an integral aspect of
Russell index methodology. Free-float adjustment means stocks are
weighted by their available market capitalization which is
calculated by multiplying the primary closing price by the
available shares. About Dyadic: Dyadic International, Inc., is
engaged in the development, manufacture and sale of biological
products (proteins, enzymes, peptides and other bio-molecules), as
well as the licensing of its enabling proprietary technology to
business collaborators for the discovery, development and
manufacture of biological products from genes. Dyadic markets its
products and services for applications in the textile, chemical,
agricultural, pulp & paper, pharmaceutical, biotechnology and
other industries, using its proprietary C1 Host Technology and C1
Expression and Screening Systems for the discovery, development and
production of biological products. About the Russell Indexes: The
information presented above about the Russell indexes and the
Russell Microcap Index is derived from the Russell Investment Group
website, http://www.russell.com. Cautionary Statement for
Forward-Looking Statements Statements contained in this press
release may contain information that includes or is based upon
certain "forward-looking statements" relating to our business. For
a discussion of the factors that could cause actual results to vary
from these forward-looking statements, please see our filings from
time to time with the Securities and Exchange Commission, which are
available free of charge on the SEC's web site at
http://www.sec.gov, including our Annual Report on Form 10-KSB for
the year ended December 31, 2004, which was filed with the SEC on
April 15, 2005, and our Quarterly Report on Form 10-QSB, which was
filed on May 17, 2005. We expressly disclaim any intent or
obligation to update any forward-looking statements.
Dyadic (AMEX:DIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Dyadic (AMEX:DIL)
Historical Stock Chart
From Jul 2023 to Jul 2024